The Center for Medicare and Medicaid Innovation today announced a new payment model for Medicare Part D and Medicare Advantage drug plans beginning January 2020, which will test new incentives for plans, patients and providers to choose drugs with lower list prices. Plans participating in the voluntary five-year model will take on greater risk for spending in the catastrophic phase of Part D and share in any resulting savings to federal reinsurance subsidy costs. The model also includes a Part D rewards and incentives program and other tools to help plans control drug costs and enrollees choose drugs with lower list prices. Also today, the Centers for Medicare & Medicaid Services announced changes to the MA Value-Based Insurance Design model for calendar year 2020, which will allow plans to provide reduced cost sharing and additional supplemental benefits to enrollees based on condition and/or socioeconomic status; bolster rewards and incentives for beneficiaries to improve their health; and increase access to telehealth services. 
 

Related News Articles

Headline
The Centers for Medicare…
Headline
Under the proposed rule, payments would increase by $37 million as compared to fiscal year 2019. CMS also estimates that site-neutral cases will continue to…
Headline
The Centers for Medicare…
Headline
The Medicare Hospital Insurance Trust Fund will have sufficient funds to pay full benefits until 2026, according to the latest annual report from the Medicare…
Headline
The Centers for Medicare & Medicaid Services late Friday issued a proposed rule updating payment rates for skilled nursing facilities for fiscal year 2020.
Headline
The Centers for Medicare & Medicaid Services today issued a proposed rule to update the payment rates for hospices for fiscal year 2020.